You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser.
Administrator
Staff member
-
cafead   Dec 17, 2024 at 12:12: PM
Administrator
Staff member
via Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in a phase 2 diabetes trial.
article source